161 related articles for article (PubMed ID: 35610302)
1. FXR expression in rats of hilar cholangiocarcinoma.
Zhang MY; Luo M; Wang JP
Sci Rep; 2022 May; 12(1):8741. PubMed ID: 35610302
[TBL] [Abstract][Full Text] [Related]
2. Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats.
Wang JP; Zhang MY; Luo M; Qin S; Xia XM
Sci Rep; 2022 Nov; 12(1):18873. PubMed ID: 36344586
[TBL] [Abstract][Full Text] [Related]
3. NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance.
Zhang MY; Luo M; He K; Xia XM; Wang JP
Technol Cancer Res Treat; 2022; 21():15330338221109646. PubMed ID: 35730199
[No Abstract] [Full Text] [Related]
4. Bsep expression in hilar cholangiocarcinoma of rat model.
Zhang MY; Wang JP; He K; Xia XM
Sci Rep; 2021 Feb; 11(1):2861. PubMed ID: 33536605
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumor of the Hilar Bile Duct.
Umezaki N; Hashimoto D; Yamashita YI; Nakagawa S; Nakao Y; Itoyama R; Yusa T; Yamao T; Okabe H; Imai K; Hayashi H; Chikamoto A; Baba H
Anticancer Res; 2019 Feb; 39(2):903-907. PubMed ID: 30711974
[TBL] [Abstract][Full Text] [Related]
6. Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma.
Deng Z; Zhao G; Wang Z; Yu L; Zou W; Li L; Liu R
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35913144
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of PIWIL2 in hilar cholangiocarcinoma tissues and cell lines.
Chen YJ; Xiong XF; Wen SQ; Tian L; Cheng WL; Qi YQ
Genet Mol Res; 2015 Jun; 14(2):7053-61. PubMed ID: 26125915
[TBL] [Abstract][Full Text] [Related]
8. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.
Tan XY; Chang S; Liu W; Tang HH
Gut Liver; 2014 Mar; 8(2):196-204. PubMed ID: 24672662
[TBL] [Abstract][Full Text] [Related]
9. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
10. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
Lozano E; Sanchez-Vicente L; Monte MJ; Herraez E; Briz O; Banales JM; Marin JJ; Macias RI
Mol Cancer Res; 2014 Jan; 12(1):91-100. PubMed ID: 24255171
[TBL] [Abstract][Full Text] [Related]
11. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
[TBL] [Abstract][Full Text] [Related]
12. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value?
Ma WJ; Shrestha A; Li FY
Cancer Med; 2016 Oct; 5(10):2848-2849. PubMed ID: 27686472
[TBL] [Abstract][Full Text] [Related]
13. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
14. Severe intrahepatic bile duct dilatation by hilar cholangiocarcinoma.
Wei DH; Peng YK; Liu W
Am J Med Sci; 2023 Jun; 365(6):e105. PubMed ID: 36572342
[No Abstract] [Full Text] [Related]
15. Placement of ¹²⁵I seed strands and stents for a type IV Klatskin tumor.
Zhang W; Yang ZQ; Shi HB; Liu S; Zhou WZ; Zhao LB
World J Gastroenterol; 2015 Jan; 21(1):373-6. PubMed ID: 25574114
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological differences between intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma].
Endo I; Matsuyama R; Mori R
Nihon Shokakibyo Gakkai Zasshi; 2016 Sep; 113(9):1541-9. PubMed ID: 27593363
[No Abstract] [Full Text] [Related]
17. [Two cases of lower bile duct recurrence resected by pancreatoduodenectomy after hepatectomy for hilar cholangiocarcinoma].
Nakahira S; Takeda Y; Kawashima H; Mukai Y; Hamanaka M; Uchiyama C; Kanemura T; Okishiro M; Takeno A; Suzuki R; Nakata K; Egawa C; Miki H; Kato T; Nakatsuka S; Tamura S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2119-21. PubMed ID: 23267996
[TBL] [Abstract][Full Text] [Related]
18. Remarkable tumor shrinkage in hilar biliary cholangiocarcinoma confirmed by peroral cholangioscopy following neoadjuvant chemotherapy.
Tomishima K; Suzuki A; Ito K; Ishii S; Fujisawa T; Fukumura Y; Isayama H
Endoscopy; 2024 Dec; 56(S 01):E85-E86. PubMed ID: 38290706
[No Abstract] [Full Text] [Related]
19. Effects of partial portal vein arterialization on the hilar bile duct in a rat model.
Guo SH; Li CH; Chen YL; Song JN; Zhang AQ; Zhou C
Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):533-8. PubMed ID: 21947729
[TBL] [Abstract][Full Text] [Related]
20. Hilar cholangiocarcinoma: pathology and tumor biology.
Kuang D; Wang GP
Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
